Seasonal Trivalent Influenza Vaccine (TIVf, Purified Surface Antigen, Inactivated, Egg Derived)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Seasonal Trivalent Influenza Vaccine (TIVf, Purified Surface Antigen, Inactivated, Egg Derived), covering 2014-03-12 to 2014-03-12. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of One Dose of Seasonal Trivalent Influenza Virus Vaccine (TIVf, Purified Surface Antigen, Inactivated, Egg Derived) in Adults, Aged 18 Years and Above [Phase 3]